The pharma company raised its guidance on revenue growth from its key treatments and expected drug launches, and now anticipates annual currency-adjusted sales to grow by 6% through 2028.
Related Posts
Inside the WSJ’s Investigation of Tesla’s Autopilot Crash Risks
The Wall Street Journal undertook a comprehensive analysis of crash data, uncovering previously obscured details by combining heavily redacted federal filings with local police records.
Financial Services Roundup: Market Talk
Find insight on Bank Jago, Perpetual and more in the latest Market Talks covering Financial Services.
Fed’s Rate Cut Is Jolting Small Businesses to Spend Again
From restarting expansion plans to boosting marketing, some entrepreneurs are preparing for lower borrowing costs. Others say not so fast.